[Thrombocyte aggregation inhibition].
Buchwald
A B
AB
Abteilung Kardiologie und Pulmologie, Georg-August-Universität, Göttingen.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D003328:Coronary Thrombosis / Q000097:blood / Q000517:prevention & control*; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000097:blood / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D013988:Ticlopidine / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin
Thrombozytenaggregationshemmung.